First Turn Management’s Praxis Precision Medicines PRAX Stock Holding History

First Turn Management's PRAX Position: Q2 2026 in Review

First Turn Management increased its Praxis Precision Medicines (PRAX) stake by 97% in Q2 2026, buying an estimated $13M and bringing the position to 83,528 shares worth $28M. The position accounts for 2.99% of the portfolio, ranked #15.

First Turn Management first reported a position in PRAX in Q4 2024 and has held it in 5 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

• First Turn Management held 83,528 shares of Praxis Precision Medicines worth $28M as of Q2 2026.
• First Turn Management bought 41,087 Praxis Precision Medicines shares in Q2 2026, an estimated $13M.
• Praxis Precision Medicines made up 2.99% of First Turn Management's portfolio in Q2 2026, its #15 holding.
• First Turn Management first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 5 quarters since.
• 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.